Navigation Links
Early Use of MS Drug May Cut Likelihood of Progression
Date:4/19/2012

THURSDAY, April 19 (HealthDay News) -- A new three-year study finds that a multiple sclerosis drug is more likely to prevent patients from progressing to a definite form of MS if it's given early in patients who appear to be ill.

The drug, a form of interferon called "interferon beta-1a," is not available in the United States. It is, however, available in countries in the European Union, Canada and elsewhere.

"While we've known it's beneficial to start MS drugs as soon as possible, this is the first trial to show a benefit of early injections of interferon beta-1a treatment at three years," Dr. Mark Freedman, of the University of Ottawa in Ontario, Canada, said in a news release from the American Academy of Neurology.

The study tracked 517 people who had brain lesions and symptoms -- such as tingling, numbness or balance problems -- that suggested they might have multiple sclerosis.

One-third of the study participants received 44-microgram doses of interferon beta-1a three times a week, one-third received the drug once a week and one-third received an inactive placebo for two years until they showed more signs of having the disease. At that point, they got the dose three times a week.

After two years, 133 people were still taking a placebo. They were then switched to the 44-microgram dose three times a week.

Those who got the drug three times a week for the entire time of the study were less likely to develop what is known as clinically definite MS. Twenty-seven percent of them did so, compared with 28 percent of those who got one dose a week for the entire period, and 41 percent of those who switched mid-stream from the placebo to the actual drug.

Side effects included flu-like symptoms, injection-site reactions and headache.

The findings were released April 19 and will be presented at the American Academy of Neurology's annual meeting, held April 21 to 28 in New Orleans.

"This
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Warren Buffett Has Early Stage Prostate Cancer
2. Detecting malaria early to save lives: New optical technique promises rapid and accurate diagnosis
3. Role of Screening, Monitoring in Early Kidney Disease Unclear
4. Brain Tumor Vaccine Shows Promise in Early Trial
5. First contact: Early intervention key in diagnosis and treatment of serious mental illness
6. Nearly 1 in 4 grandparents store prescription medicines where children can easily find them
7. Eye Tremors May Aid Early Diagnosis of Parkinsons: Study
8. JCI early table of contents for April 9, 2012
9. Treat Rheumatoid Arthritis Early and Aggressively: Guidelines
10. Early Study Finds Some Promise for Lung Cancer Vaccine
11. An Early Start for Your Child with Autism
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Early Use of MS Drug May Cut Likelihood of Progression
(Date:7/30/2015)... ... ... As more hospitals across the country see the value in developing their ... of growing competition, it is more important than ever to market a hospital’s ... at Wound Care Advantage has found that while many hospitals already have ...
(Date:7/30/2015)... ... 2015 , ... In an effort to provide the twenty four hour continuous ... in his practice. , The decision will also allow him to spend more time ... transferring his in-patient admissions to the hospitalists at East Liverpool City Hospital.Dr. Aggarwal has ...
(Date:7/30/2015)... ... July 30, 2015 , ... Zaca Life has ... go. With no water needed, the refreshing berry-flavored tablets are the perfect travel ... the natural ingredients that may help with body detoxification, protection and hydration,” said ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... Mid-Atlantic region, is the recipient of three awards in the Service Industry Advertising ... programs created for Choptank Transport, KRM Development Corporation and University of Maryland Shore ...
(Date:7/30/2015)... ... 30, 2015 , ... Well-known San Diego AC, plumbing and ... cost service and repair companies. For 35 years, they have grown both their ... to meet the demands of the changing technological environment. , To ...
Breaking Medicine News(10 mins):Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 2Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 3Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 2Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 3
... , , IRVING, Texas, June 22 RBC ... of proprietary nutritional supplements and wound care/pain management products, ... reduced lactic acid buildup and improved hydration in horses ... Rutgers University study corroborates more than a dozen ...
... Add RALS(R)-Plus Module to Company,s Hemoglobin and Glucose Handheld ... HemoCue Inc., the U.S. point-of-care testing distribution ... ), today announced that it has signed an agreement ... of a RALS(R)-Plus module for the HemoCue 201 DM ...
... where others have failed , MONDAY, June 22 (HealthDay News) ... the United States could prove to be the toughest challenge ... reach that long-elusive goal, it would not only guarantee his ... experts say. , "Assuming that President Obama gets ...
... Increase Profitability and Deliver Higher Quality, Cost Effective Solutions , , ... , News Facts , , ... and growth of its health sciences partner ecosystem, Oracle is delivering new ... suite of software applications for clinical development and drug safety. , ...
... In the ... independent media and web sites, including information on mind-body healing, meditation, yoga, and Ayurveda offered ... ... more than five million Internet sites banned by the Iranian government since 2008. In the ...
... , HAIKOU CITY, China, ... Pharma") (OTC Bulletin Board: CPHI), which develops,manufactures, and ... it has received official approval from China,s State ... and Phase II clinical trials to,test the efficacy ...
Cached Medicine News:Health News:Horse Study: RBC Life Sciences' Antioxidant, Microhydrin, Reduced Lactic Acid Buildup and Improved Hydration During Strenuous Exercise 2Health News:Horse Study: RBC Life Sciences' Antioxidant, Microhydrin, Reduced Lactic Acid Buildup and Improved Hydration During Strenuous Exercise 3Health News:Quest Diagnostics HemoCue Subsidiary to Add U.S. Hospital Laboratory Connectivity to Its HemoCue 201 DM Point-of-Care Systems 2Health News:Quest Diagnostics HemoCue Subsidiary to Add U.S. Hospital Laboratory Connectivity to Its HemoCue 201 DM Point-of-Care Systems 3Health News:Health-Care Reform Could Be Obama's Toughest Challenge 2Health News:Health-Care Reform Could Be Obama's Toughest Challenge 3Health News:Health-Care Reform Could Be Obama's Toughest Challenge 4Health News:Oracle Focuses on Health Sciences Partner Enablement, Growth, and Accreditation 2Health News:Oracle Focuses on Health Sciences Partner Enablement, Growth, and Accreditation 3Health News:Oracle Focuses on Health Sciences Partner Enablement, Growth, and Accreditation 4Health News:Iran Blocks Access to the Chopra Center's Web Site, Podcasts, and Blogs 2Health News:Iran Blocks Access to the Chopra Center's Web Site, Podcasts, and Blogs 3Health News:China Pharma Holdings, Inc. Announces SFDA Approval for Rosuvastatin Clinical Trials 2Health News:China Pharma Holdings, Inc. Announces SFDA Approval for Rosuvastatin Clinical Trials 3
(Date:7/31/2015)... July 31, 2015  Xencor, Inc. (NASDAQ: XNCR ... for the treatment of autoimmune diseases, asthma and allergic ... Yujiro S. Hata to its board of directors. ... and corporate development is a tremendous asset to our ... chief executive officer of Xencor. "Xencor faces a range ...
(Date:7/30/2015)... , July 30, 2015 Edwards Lifesciences Corporation ... of heart valves and hemodynamic monitoring, today announced that ... of Directors. "Bob is an ardent champion for ... true privilege to have him on Edwards, board as we ... , Edwards, chairman and CEO.  "Bob has provided a valuable ...
(Date:7/30/2015)... Calif. , July 30, 2015 IRIDEX ... will release its second quarter 2015 financial results after ...   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, ... the quarter and other business developments. Interested ...
Breaking Medicine Technology:Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2
... Intercell AG (VSE: ICLL) today announced that effective ... Management Board as Chief Business Officer with key responsibilities ... Marketing and Sales, Corporate and Business Development, and Alliance ... the other Management Board members in helping drive forward ...
... 30 Reportlinker.com announces that a new market ... Global Optoelectronics Industry ... the worldwide markets for Optoelectronics in Millions of ... & Systems, and Optical Components. Major segments analyzed ...
Cached Medicine Technology:Intercell AG Appoints Staph Leavenworth Bakali as Chief Business Officer 2Reportlinker Adds Global Optoelectronics Industry 2Reportlinker Adds Global Optoelectronics Industry 3Reportlinker Adds Global Optoelectronics Industry 4Reportlinker Adds Global Optoelectronics Industry 5Reportlinker Adds Global Optoelectronics Industry 6Reportlinker Adds Global Optoelectronics Industry 7Reportlinker Adds Global Optoelectronics Industry 8Reportlinker Adds Global Optoelectronics Industry 9Reportlinker Adds Global Optoelectronics Industry 10Reportlinker Adds Global Optoelectronics Industry 11Reportlinker Adds Global Optoelectronics Industry 12Reportlinker Adds Global Optoelectronics Industry 13Reportlinker Adds Global Optoelectronics Industry 14Reportlinker Adds Global Optoelectronics Industry 15Reportlinker Adds Global Optoelectronics Industry 16Reportlinker Adds Global Optoelectronics Industry 17Reportlinker Adds Global Optoelectronics Industry 18Reportlinker Adds Global Optoelectronics Industry 19Reportlinker Adds Global Optoelectronics Industry 20Reportlinker Adds Global Optoelectronics Industry 21Reportlinker Adds Global Optoelectronics Industry 22Reportlinker Adds Global Optoelectronics Industry 23Reportlinker Adds Global Optoelectronics Industry 24Reportlinker Adds Global Optoelectronics Industry 25
... DiscoverySE Centrifuges. Workhorse. All in one. ... the new Sorvall Discovery 100SE Ultracentrifuge ... features come with top-of-the-line performance, powerful ... all built into the smallest, quietest, ...
... DiscoveryTMM150 SE Micro-ultra centrifuge continues to raise ... processing, now with 1,048,000 x g performance ... DiscoveryTMM150SE processes sample sizes from 0.2 ... floor footprint, brushless direct drive, very quiet ...
... the highest g-force ever. But optimal productivity ... Optima MAX combines maximum force, capacity, and ... that's worlds apart from any other system. ... enhanced efficiency, Optima takes productivity to the ...
... Efficiency, versatility, and environmental safety ... Optima LE-80 K Ultracentrifuge from ... innovative Optima centrifugation technology, the ... cost effectively provide advanced capability ...
Medicine Products: